SPDR S&P Bank (KBE) 옵션

Coincidence or inside info??

https://media.gettr.com/group7/getter/2025/03/26/12/518d3618-c9ae-959a-04ff-6838710954b6/cb1235f4a9f1925ff62777f71274df67_768x0.jpg

While the FDA doesn't directly "approve" clinical trials conducted in India, it does accept data from clinical investigations conducted outside the United States to support medical device applications and submissions, including those in India.

Here's a more detailed breakdown:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175965689

I misunderstood as I did not realize you were referring to issuing financials.

Hard to tell when, but lack of communication and what is the hold up.

.23 back to premarket highs + 280% exit mandatory cash it all in $$$.Been busy shorting the markets but always some good penny plays 

Can someone translate this minced into negativity statement?

Is it what I think it is..?

ie he is neither following what is unfolding or he's not following what is unfolding?

And/or is it worth thinking about?

Maybe not..

No

Even at today's volume $19k won't pay off much debt. Schlenk has really screwed over shareholders for years.

It wasnt me it was the mods. Keep whining.

Same one that said it was over subscribed?

ASK slaps are coming in but are traded as a black half tick discount trade at .006 instead of .0061

It starts converting in 6 Months:

Conversion Mechanics. Lender has the right at any time after the six-month anniversary of the Effective Date until the Outstanding Balance has been paid in full, at its election, to convert (“Conversion”) all or any portion of the Outstanding Balance

Lqmt 10-12cents should be base, if news comes about this could go parabolic. Licensing fees in automotive assemblies need to come about and could carry a hefty price tag...

$BURU -Elimination of 100% of Long-Term Indebtedness Allows Financial Flexibility for Future Transactions. Strategic Relationship Amplifies NUBURU's Capital-Light Transformation and Expands Innovative Solutions for Critical Industries. www.nuburu.net

Looks like our new board is acting like our old board when it comes to activist investors ! Figures maybe they needed some comic strips presentations like Denner did

Michael

$BURU -Elimination of 100% of Long-Term Indebtedness Allows Financial Flexibility for Future Transactions. Strategic Relationship Amplifies NUBURU's Capital-Light Transformation and Expands Innovative Solutions for Critical Industries. www.nuburu.net

Well, Bobby what seems to be your problem? I thought you were a big time swing trader with Biel. Buy at .0001. Sell at .0003. Triple your money with one move.

It’s a humbling feeling for sure, lots of emotions to process. I have worked straight for 38 years and never once been fired or laid off from any job!! Corporate America can be a bitch…

Well then- let's charge everyone on that chat!

Kyle Griffin? ?@kylegriffin1.bsky.social?


NBC News: The Espionage Act contains a provision making it crime to disclose national defense secrets "through gross negligence."

The law does not require in

I'm looking to make hundreds of thousands here myself 🤑
Whomever is still hanging on to shares here are my friends at the table

Just another gambler looking for a place to eat 🎰🥤🍔🍟🍦cause I'm m fat asf

Thanks, I will add to my BTC watch list. Ive traded both of these many times in past.
It by itself can make good money but it can frustrate also. BTC goes up and MARA goes down or sideways. Then it will spike for no reason.

Back in the Old Days--FXY//SPY was a mainstay ---Very Popular !!

$COEP #Nasdaq Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform
https://finance.yahoo.com/news/coeptis-therapeutics-announces-first-customer-130000003.html

Hey, misrerfishman. 
The only stock Bubae is holding is OMID. So maybe you should go irritate him over there. Bubae bought this at 0.05, now trading at 0.017. He only had money to buy 3000 shares bc he lost all his money in the past. OMID will soon go BK I hear. They don't even have a woring

$COEP #Nasdaq Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform
https://finance.yahoo.com/news/coeptis-therapeutics-announces-first-customer-130000003.html